Severe morbidity among hospitalised adults with acute influenza and other respiratory infections: 2014-2015 and 2015-2016.
Severe morbidity among hospitalised adults with acute influenza and other respiratory infections: 2014-2015 and 2015-2016.
复制标题
住院的成年人患有急性流感和其他呼吸道感染的严重发病率:2014-2015和2015-2016。
DOI:
10.1017/s0950268818001486
复制
发表时间:
2018-08
影响因子:
4.2
通讯作者:
Martin ET
中科院分区:
文献类型:
--
作者:
Segaloff HE;Petrie JG;Malosh RE;Cheng CK;McSpadden EJ;Ferdinands JM;Lamerato L;Lauring AS;Monto AS;Martin ET
Our objective was to identify predictors of severe acute respiratory infection in hospitalized patients and understand the impact of vaccination and neuraminidase inhibitor administration on severe influenza. We analyzed data from a study evaluating influenza vaccine effectiveness in two Michigan hospitals during the 2014–2015 and 2015–2016 influenza seasons. Adults admitted to the hospital with an acute respiratory infection were eligible. Through patient interview and medical record review, we evaluated potential risk factors for severe disease, defined as ICU admission, 30-day readmission, and hospital length of stay. Two hundred of 1072 participants had PCR-confirmed influenza. Frailty score, Charlson score, and tertile of prior-year health care visits were associated with length of stay. Charlson score >2 (OR:1.6[1.0, 2.4]) was associated with ICU admission. Highest tertile of prior-year visits (OR:0.4[0.2, 0.7]) was associated with decreased ICU admission. Increasing tertile of visits (OR: 1.4[1.2, 1.8]) was associated with 30-day readmission. Frailty and prior-year health care visits were associated with 30-day readmission among influenza-positive participants. Neuraminidase inhibitors were associated with decreased length of stay among vaccinated participants with influenzaA (HR:1.6 [1.0, 2.4]). Overall, frailty and lack of prior-year health care visits were predictors of disease severity. Neuraminidase inhibitors were associated with reduced severity among vaccine recipients.